Advertisement

Topics

Takeda and Molecular Templates Collaborate for Next-Generation Oncology Therapies

16:09 EDT 3 Aug 2017 | Speciality Pharma Journal

OSAKA, Japan & AUSTIN, Texas–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply Molecular Templates’ engineered toxin bodies (ETB) technology platform to potential therapeutic targets provided by Takeda through a joint scientific committee of both companies. “Over the past …

Original Article: Takeda and Molecular Templates Collaborate for Next-Generation Oncology Therapies

NEXT ARTICLE

More From BioPortfolio on "Takeda and Molecular Templates Collaborate for Next-Generation Oncology Therapies"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...